JIYA ACQUISITION CORP's ticker is JYAC and the CUSIP is 47760M102. A total of 59 filers reported holding JIYA ACQUISITION CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,988,000 | +0.3% | 400,000 | -0.6% | 0.00% | 0.0% |
| Q2 2022 | $3,977,000 | -0.1% | 402,555 | -0.6% | 0.00% | 0.0% |
| Q1 2022 | $3,982,000 | -4.1% | 405,110 | -4.7% | 0.00% | 0.0% |
| Q4 2021 | $4,154,000 | -2.2% | 425,146 | -2.4% | 0.00% | -33.3% |
| Q3 2021 | $4,248,000 | -1.9% | 435,713 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,331,000 | +10.0% | 435,713 | +8.9% | 0.00% | 0.0% |
| Q1 2021 | $3,936,000 | -4.5% | 400,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $4,120,000 | – | 400,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 562,500 | $5,524,000 | 2.58% |
| Samsara BioCapital, LLC | 507,041 | $4,984,000 | 1.26% |
| Altium Capital Management LP | 200,000 | $1,966,000 | 0.66% |
| Bain Capital Life Sciences Investors, LLC | 300,000 | $2,949,000 | 0.29% |
| GLAZER CAPITAL, LLC | 1,003,386 | $9,853,000 | 0.28% |
| Integrity Capital Management (HK) Ltd | 5,000 | $49,000 | 0.25% |
| Spartan Fund Management Inc. | 100,000 | $1,228,000 | 0.20% |
| Context Capital Management, LLC | 300,000 | $2,949,000 | 0.19% |
| PFM Health Sciences, LP | 464,103 | $4,562,000 | 0.17% |
| EcoR1 Capital, LLC | 500,000 | $4,915,000 | 0.15% |